Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05200065

Thulium Laser Versus Bipolar Enucleation of the Prostate

Conditions: Benign Prostatic Hyperplasia

Sex: Male
Healthy volunteers: Yes
Phase: NA
Enrollment: 60
Sponsor: Cairo University

Location: Kasr AlAiny School of Medicine Cairo Cairo Governorate

Summary

Comparing the peri-operative outcomes in patients with benign prostatic hyperplasia (BPH) who will undergo bipolar enucleation of the prostate versus thulium laser enucleation.

Eligibility Criteria

Inclusion Criteria: 1. Patients with BPH who are unsatisfied with medical treatment having a Qmax of less than 15 cm/s. 2. Patients with BPH who had refractory retention. 3. Patients with complicated BPH (eg; chronic retention, refractory hematuria, bladder stones). 4. Prostate size of at least 80 grams or more. Exclusion Criteria: 1. Patients with a bladder mass. 2. Patients with prostate cancer. 3. Patients suffering from a urethral stricture. 4. Patients with previous endoscopic or surgical prostate intervention. 5. Prostate size less than 80 grams.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05200065). StuddyBuddy aggregates publicly available trial information.